Comparison of focal boost high dose rate prostate brachytherapy optimisation methods.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 26411294.
- Also identified by DOI 10.1016/j.radonc.2015.09.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
For HDR prostate brachytherapy treatments of 15 Gy to the whole gland plus focal boost, optimisation to either tumour plus margin (F-PTV) or involved sectors was compared. For 15 patients median F-PTV D90 and V150 were 21.0 Gy and 77.2% for F-PTV optimisation and 19.8 Gy and 75.6% for sector optimisation.
Medical subject headings
- Brachytherapy
- Prostatic Neoplasms